Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #31
    Passenger versus Driver

    Hi,

    how do you interprete the oncofuse output based on the definitions below?

    low P_VAL_CORR => likely passenger?
    high DRIVER_PROB => likely driver?
    EXPRESSION_GAIN => how are 5'/3' expressions computed?

    I have these two lines for instance which seem contradictory:
    1130 0 KDR Yes Exon 6 1 1138 2 2 5.616331914947E-5 0.9999999839119682 0.7550226777191273 Pleckstrin homology-like domain[Domain];Arf GTPase activating protein[Family];Pleckstrin homology domain[Domain];Arfaptin homology (AH) domain/BAR domain[Domain];Src homology-3 domain[Domain];Ankyrin repeat-containing domain[Domain];Ankyrin repeat[Repeat] Immunoglobulin-like domain[Domain];Immunoglobulin subtype 2[Domain];Immunoglobulin subtype[Domain];Serine-threonine/tyrosine-protein kinase catalytic domain[Domain];Immunoglobulin-like fold[Domain];Protein kinase, ATP binding site[Binding_site];Tyrosine-protein kinase, receptor class III, conserved site[Conserved_site];Immunoglobulin I-set[Domain];Tyrosine-protein kinase, active site[Active_site];Protein kinase-like domain[Domain];Immunoglobulin V-set domain[Domain];Tyrosine-protein kinase, catalytic domain[Domain];Protein kinase domain[Domain];Vascular endothelial growth factor receptor 2 (VEGFR2)[Family] GRB2;SRC KDR;NCK1;PLCG1;PTPN6;SHC1;SRC;VEGFA;VEGFC;NRP1;SH2D2A;SHC2;FLT4;FYN;GRB2;GRB10 0.031693123551895894 0.060912399971582896 0.0011108580362268734 0.08982267991811016 0.03377877733466933 0.01758896057545965
    679 0 CLTC Yes Exon 10 31 1159 0 0 4.159324576929766E-4 0.9999996425673524 -0.33165129627027434 Zinc finger, C2H2-like[Domain] Clathrin, heavy chain/VPS, 7-fold repeat[Repeat];Clathrin, heavy chain[Family];Tetratricopeptide-like helical[Domain];Armadillo-type fold[Domain] Zinc finger, C2H2-like[Domain] CLTC;CLTA;CLTB 0.00561979753630853 0.0 3.7249030480169165E-5 0.0 0.0011034671362001604 0.018050986438399443


    P_VAL_CORR

    The Bayesian probability of fusion being a passenger (class 0), given as Bonferroni-corrected P-value.
    DRIVER_PROB

    The Bayesian probability of fusion being a driver (class 1).
    EXPRESSION_GAIN

    Expression gain of fusion calculated as:

    [(expression of 5' gene)/(expression of 3' gene)]-1

    Thanks,

    Comment


    • #32
      Originally posted by sthor View Post
      Hi,

      how do you interprete the oncofuse output based on the definitions below?

      low P_VAL_CORR => likely passenger?
      high DRIVER_PROB => likely driver?
      EXPRESSION_GAIN => how are 5'/3' expressions computed?

      I have these two lines for instance which seem contradictory:
      1130 0 KDR Yes Exon 6 1 1138 2 2 5.616331914947E-5 0.9999999839119682 0.7550226777191273 Pleckstrin homology-like domain[Domain];Arf GTPase activating protein[Family];Pleckstrin homology domain[Domain];Arfaptin homology (AH) domain/BAR domain[Domain];Src homology-3 domain[Domain];Ankyrin repeat-containing domain[Domain];Ankyrin repeat[Repeat] Immunoglobulin-like domain[Domain];Immunoglobulin subtype 2[Domain];Immunoglobulin subtype[Domain];Serine-threonine/tyrosine-protein kinase catalytic domain[Domain];Immunoglobulin-like fold[Domain];Protein kinase, ATP binding site[Binding_site];Tyrosine-protein kinase, receptor class III, conserved site[Conserved_site];Immunoglobulin I-set[Domain];Tyrosine-protein kinase, active site[Active_site];Protein kinase-like domain[Domain];Immunoglobulin V-set domain[Domain];Tyrosine-protein kinase, catalytic domain[Domain];Protein kinase domain[Domain];Vascular endothelial growth factor receptor 2 (VEGFR2)[Family] GRB2;SRC KDR;NCK1;PLCG1;PTPN6;SHC1;SRC;VEGFA;VEGFC;NRP1;SH2D2A;SHC2;FLT4;FYN;GRB2;GRB10 0.031693123551895894 0.060912399971582896 0.0011108580362268734 0.08982267991811016 0.03377877733466933 0.01758896057545965
      679 0 CLTC Yes Exon 10 31 1159 0 0 4.159324576929766E-4 0.9999996425673524 -0.33165129627027434 Zinc finger, C2H2-like[Domain] Clathrin, heavy chain/VPS, 7-fold repeat[Repeat];Clathrin, heavy chain[Family];Tetratricopeptide-like helical[Domain];Armadillo-type fold[Domain] Zinc finger, C2H2-like[Domain] CLTC;CLTA;CLTB 0.00561979753630853 0.0 3.7249030480169165E-5 0.0 0.0011034671362001604 0.018050986438399443


      P_VAL_CORR

      The Bayesian probability of fusion being a passenger (class 0), given as Bonferroni-corrected P-value.
      DRIVER_PROB

      The Bayesian probability of fusion being a driver (class 1).
      EXPRESSION_GAIN

      Expression gain of fusion calculated as:

      [(expression of 5' gene)/(expression of 3' gene)]-1

      Thanks,
      Hello!

      DRIVER_PROB means the probability (in Bayesian sense) of being a driver mutation.

      The same in represented by P-value, the probability of being a passanger, with one major difference. P_VAL_CORR = FDR(1-DRIVER_PROB), where FDR represents Benjamini-Hochberg corrected P-values.

      Expression gain is calculated based on gene expression values in normal tissue, according to library option. The corresponding routine uses the gene expression data provided with Oncofuse bundle.

      So both of them are putative drivers, with promoter swapping being possible mechanism in the first case.

      ---

      PS
      Just in case, I'm adding the link to source code repository of Oncofuse containing the latest release: https://github.com/mikessh/oncofuse
      Last edited by mikesh; 11-24-2014, 09:11 AM.

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Strategies for Sequencing Challenging Samples
        by seqadmin


        Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
        03-22-2024, 06:39 AM
      • seqadmin
        Techniques and Challenges in Conservation Genomics
        by seqadmin



        The field of conservation genomics centers on applying genomics technologies in support of conservation efforts and the preservation of biodiversity. This article features interviews with two researchers who showcase their innovative work and highlight the current state and future of conservation genomics.

        Avian Conservation
        Matthew DeSaix, a recent doctoral graduate from Kristen Ruegg’s lab at The University of Colorado, shared that most of his research...
        03-08-2024, 10:41 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, Yesterday, 06:37 PM
      0 responses
      10 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, Yesterday, 06:07 PM
      0 responses
      9 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 03-22-2024, 10:03 AM
      0 responses
      49 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 03-21-2024, 07:32 AM
      0 responses
      67 views
      0 likes
      Last Post seqadmin  
      Working...
      X